Seelos Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 61.47 | -100% | -0.1081 | -100% |
| P/S |
|
3.47 | 33.58 | -89.67% |
|
|
| P/BV |
|
-0.2281 | 4.79 | -104.76% |
|
|
| P/FCF |
|
0 | 61 | -100% |
|
|
| Ev/Ebitda |
|
-0.4668 | -17.26 | -97.3% |
|
|
| Ev/S |
|
8.57 | 22.5 | -61.92% |
|
|
| Ev/FCF |
|
-0.7894 | 69 | -101.14% |
|
|
| E/P |
|
0 | 0.0178 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-1835.77 | 4.97 | -37021.64% | -4802.37 | -61.77% |
| ROE |
|
113.05 | 9.61 | 1076.15% |
|
|
| ROA |
|
-699.19 | 0.3443 | -203199.12% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-1719.56 | -25.17 | 6731.75% |
|
|
| ROCE |
|
120.86 | 15.19 | 695.84% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.3518 | -3.67 | -90.41% | -0.3275 | +7.43% |
| Nеt Debt/Ebitda |
|
-0.2777 | -4.06 | -93.16% |
|
|
| Debt/Ratio |
|
2.63 | 0.199 | 1219.56% |
|
|
| Debt/Equity |
|
0.6268 | 1.54 | -59.38% |
|
|
| Debt/Net Income |
|
-0.3756 | 10.34 | -103.63% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5399 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2256 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9598 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4928 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5399 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-61.77 | 76.2 | -181.06% | ||
| Growth impulse Ebitda in 5 years |
|
38.03 | 44.75 | -15.02% | ||
| Growth impulse Net Income in 5 years |
|
-47.39 | -15.36 | 208.53% | ||
| Growth impulse FCF in 5 years |
|
23.9 | -108.72 | -121.98% | ||
| Growth impulse EPS in 5 years |
|
118.38 | -142.05 | -183.34% |
IP Score
4.04/10
